ACH
NXTC icon

ArrowMark Colorado Holdings’s NextCure NXTC Stock Holding History

ArrowMark Colorado Holdings’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-19,071
Closed -$1.84M – 365
2021
Q2 		$1.84M Hold
19,071
– – 0.01% 274
2021
Q1 		$2.29M Sell
19,071
-40,709
-68% -$5.9M 0.02% 267
2020
Q4 		$7.82M Sell
59,780
-486
-0.8% -$62.8K 0.06% 201
2020
Q3 		$6.36M Sell
60,266
-652
-1% -$80.2K 0.06% 192
2020
Q2 		$15.7M Sell
60,918
-90
-0.1% -$34.3K 0.16% 113
2020
Q1 		$27.1M Sell
61,008
-2,448
-4% -$1.31M 0.36% 76
2019
Q4 		$42.9M Buy
63,456
+59,289
+1,423% +$29.7M 0.38% 78
2019
Q3 		$1.54M Hold
4,167
– – 0.02% 231
2019
Q2 		$749K Buy
+4,167
New +$866K 0.01% 284

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ArrowMark Colorado Holdings's NXTC Position: Q3 2021 in Review

ArrowMark Colorado Holdings sold out of NextCure (NXTC) in Q3 2021, closing a stake of 19,071 shares — an estimated $1.84M sold.

ArrowMark Colorado Holdings first reported a position in NXTC in Q2 2019 and held it in 9 quarters. The position peaked at $42.9M in Q4 2019. 71 funds tracked by Wall St. Rank hold NXTC as of Q3 2021.

  • ArrowMark Colorado Holdings reported no remaining NextCure position as of Q3 2021 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 19,071 NextCure shares in Q3 2021, an estimated $1.84M.
  • ArrowMark Colorado Holdings first reported a position in NextCure in Q2 2019 and held it in 9 quarters.
  • ArrowMark Colorado Holdings's NextCure position peaked at $42.9M in Q4 2019.
  • 71 funds tracked by Wall St. Rank held NextCure as of Q3 2021.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2021, filed 15 Nov 2021.